scispace - formally typeset
J

Joseph Loscalzo

Researcher at Brigham and Women's Hospital

Publications -  875
Citations -  79338

Joseph Loscalzo is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Nitric oxide & Platelet. The author has an hindex of 129, co-authored 828 publications receiving 71573 citations. Previous affiliations of Joseph Loscalzo include Veterans Health Administration & University of California, Los Angeles.

Papers
More filters
Patent

Compositions and methods for treating hypertension

TL;DR: The technology described in this article is directed to agents that reduce the level of oxidant-modified ET-B Cys405, Cys403, or Cys402 and the identification and use of such agents for, e.g. to treat hypertension.
Journal ArticleDOI

Stanching the Flow: The Evolution of Vertebrate Blood Clotting by Russell F. Doolittle (2012)

TL;DR: The clotting of blood in response to injury is a primordial\ but highly efficient and complex affair, the analysis of which remains a challenge.
Patent

Pharmaceutical composition containing S-nitroso-lipoproteins and use thereof

TL;DR: The use of S-nitroso-lipoprotein for regulating protein function, cellular metabolism and effecting vasodilation, platelet inhibition, relaxation of non-vascular smooth muscle and to deliver nitric oxide in its most bioactive form in order to achieve the effects described above as discussed by the authors.
Journal ArticleDOI

Superior Mesenteric Artery Dissection: Classical Presentation, Novel Genetic Determinants.

TL;DR: A case of superior mesenteric artery dissection prompting clinical genetic testing to investigate the underlying mechanisms of the vasculopathy is presented.
Journal ArticleDOI

The Problem of Irreproducible Bioscience Research

TL;DR: In this paper , the meaning of research reproducibility and the factors that contribute to irreproducibility in biomedical research have been discussed, as well as potential interventions to counter the current level of irreducibility aimed at increasing the efficiency and impact of society's substantial and critically important investment in bioscience research.